Universal Vision Biotechnology Co Ltd
Universal Vision Biotechnology Co., Ltd. operates a chain of eye care clinics in Taiwan and China. The company offers optical devices, glasses, lens, and vision aid products. It is also involved in leasing of medical devices. In addition, the company offers hospital management, optometric, and technical consultancy services, as well as provides medical and scientific prescription eyeglasses. Furt… Read more
Universal Vision Biotechnology Co Ltd (3218) - Total Liabilities
Latest total liabilities as of September 2025: NT$2.07 Billion TWD
Based on the latest financial reports, Universal Vision Biotechnology Co Ltd (3218) has total liabilities worth NT$2.07 Billion TWD as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Universal Vision Biotechnology Co Ltd - Total Liabilities Trend (2003–2024)
This chart illustrates how Universal Vision Biotechnology Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Universal Vision Biotechnology Co Ltd Competitors by Total Liabilities
The table below lists competitors of Universal Vision Biotechnology Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Polyrocks Chemical Co Ltd
SHG:688669
|
China | CN¥3.88 Billion |
|
LOG Commercial Properties e Participações S.A
SA:LOGG3
|
Brazil | R$3.20 Billion |
|
Lever Global Corporation
OTCQB:LVER
|
USA | $1.13 Million |
|
KT Submarine Co. Ltd
KQ:060370
|
Korea | ₩79.71 Billion |
|
AB Fagerhult
F:2F0
|
Germany | €5.73 Billion |
|
Bank of Ayudhya PCL
BK:BAY
|
Thailand | ฿2.16 Trillion |
|
Bharat Bijlee Limited
NSE:BBL
|
India | ₹9.14 Billion |
|
UE Furniture Co Ltd
SHG:603600
|
China | CN¥2.28 Billion |
Liability Composition Analysis (2003–2024)
This chart breaks down Universal Vision Biotechnology Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.46 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.56 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.35 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Universal Vision Biotechnology Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Universal Vision Biotechnology Co Ltd (2003–2024)
The table below shows the annual total liabilities of Universal Vision Biotechnology Co Ltd from 2003 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | NT$2.01 Billion | +12.27% |
| 2023-12-31 | NT$1.79 Billion | +6.63% |
| 2022-12-31 | NT$1.68 Billion | +17.96% |
| 2021-12-31 | NT$1.42 Billion | +25.80% |
| 2020-12-31 | NT$1.13 Billion | +18.69% |
| 2019-12-31 | NT$951.83 Million | +95.08% |
| 2018-12-31 | NT$487.91 Million | +15.73% |
| 2017-12-31 | NT$421.59 Million | -27.67% |
| 2016-12-31 | NT$582.88 Million | -21.24% |
| 2015-12-31 | NT$740.12 Million | +11.80% |
| 2014-12-31 | NT$662.01 Million | +148.08% |
| 2013-12-31 | NT$266.86 Million | +11.96% |
| 2012-12-31 | NT$238.35 Million | -2.63% |
| 2011-12-31 | NT$244.78 Million | -29.49% |
| 2010-12-31 | NT$347.16 Million | -20.51% |
| 2009-12-31 | NT$436.73 Million | -20.71% |
| 2008-12-31 | NT$550.78 Million | +434.95% |
| 2007-12-31 | NT$102.96 Million | +96.08% |
| 2006-12-31 | NT$52.51 Million | -32.51% |
| 2004-12-31 | NT$77.81 Million | +7.74% |
| 2003-12-31 | NT$72.21 Million | -- |